[ { "journalSlug": "nature", "journalName": "Nature", "publisherName": "Springer Nature", "fieldPrimary": "Multidisciplinary", "openAccessModel": "hybrid", "impactFactorDisplay": "48.5", "acceptanceRateDisplay": "<8%", "acceptanceRateType": "estimated", "reviewTimeDeskDays": 7, "reviewTimeDeskDisplay": "~7 days", "reviewTimeFirstDecisionDays": 70, "reviewTimeFirstDecisionDisplay": "~8–12 weeks", "reviewTimeType": "estimated", "deskRejectRateDisplay": ">90%", "deskRejectRateType": "estimated", "submissionWordLimitDisplay": "~3,000 (main text)", "abstractFormat": "Unstructured", "abstractWordLimitDisplay": "150", "figureLimitDisplay": "6 display items", "referenceLimitDisplay": "50", "fitSignals": [ "cross-disciplinary importance is obvious without explanation theater", "the evidence package feels complete, not suggestive" ], "commonRejectionReasons": [ "strong but field-bound advance framed as general science", "headline claim outruns the underlying evidence" ], "editorialModelSummary": "Nature is an extreme breadth-and-significance filter. Most technically strong but narrower papers are rejected at editorial triage before review.", "manusightsDifficultyScore": 98, "manusightsDifficultyBand": "extreme", "sourceConfidence": "mixed", "sourceCount": 4, "lastReviewedAt": "2026-03-30", "versionTag": "2026.03.30-mvp1" }, { "journalSlug": "science", "journalName": "Science", "publisherName": "AAAS", "fieldPrimary": "Multidisciplinary", "openAccessModel": "hybrid", "impactFactorDisplay": "45.8", "acceptanceRateDisplay": "<7%", "acceptanceRateType": "estimated", "reviewTimeDeskDays": 14, "reviewTimeDeskDisplay": "~14 days", "reviewTimeFirstDecisionDays": 70, "reviewTimeFirstDecisionDisplay": "8–12 weeks", "reviewTimeType": "estimated", "deskRejectRateDisplay": ">90%", "deskRejectRateType": "estimated", "submissionWordLimitDisplay": "~4,500", "abstractFormat": "Unstructured", "abstractWordLimitDisplay": "125", "figureLimitDisplay": "6–8 display items", "referenceLimitDisplay": "55", "fitSignals": [ "the result changes how a broad scientific audience thinks", "the framing is concise and accessible outside one specialty" ], "commonRejectionReasons": [ "excellent but not field-shifting work", "specialist story with limited cross-disciplinary consequence" ], "editorialModelSummary": "Science screens first for broad significance and general scientific consequence, not just technical merit.", "manusightsDifficultyScore": 97, "manusightsDifficultyBand": "extreme", "sourceConfidence": "mixed", "sourceCount": 4, "lastReviewedAt": "2026-03-30", "versionTag": "2026.03.30-mvp1" }, { "journalSlug": "cell", "journalName": "Cell", "publisherName": "Cell Press", "fieldPrimary": "Cell & Molecular Biology", "openAccessModel": "hybrid", "impactFactorDisplay": "42.5", "acceptanceRateDisplay": "<8%", "acceptanceRateType": "estimated", "reviewTimeDeskDays": 14, "reviewTimeDeskDisplay": "~14 days", "reviewTimeFirstDecisionDays": 56, "reviewTimeFirstDecisionDisplay": "6–10 weeks", "reviewTimeType": "estimated", "deskRejectRateDisplay": ">85%", "deskRejectRateType": "estimated", "submissionWordLimitDisplay": "~6,000–8,000", "abstractFormat": "Unstructured", "abstractWordLimitDisplay": "150", "figureLimitDisplay": "7–8 main figures", "referenceLimitDisplay": "100", "fitSignals": [ "the mechanism is both complete and broadly interesting", "the paper feels final rather than one experiment short" ], "commonRejectionReasons": [ "flashy mechanism without enough closure", "important biology that still feels too narrow or incomplete" ], "editorialModelSummary": "Cell rewards mechanistic completeness and broad biological consequence, and rejects many promising but still-incomplete stories early.", "manusightsDifficultyScore": 95, "manusightsDifficultyBand": "extreme", "sourceConfidence": "mixed", "sourceCount": 4, "lastReviewedAt": "2026-03-30", "versionTag": "2026.03.30-mvp1" }, { "journalSlug": "nejm", "journalName": "New England Journal of Medicine", "publisherName": "Massachusetts Medical Society", "fieldPrimary": "Clinical Medicine", "openAccessModel": "hybrid", "impactFactorDisplay": "78.5", "acceptanceRateDisplay": "<5%", "acceptanceRateType": "reported", "reviewTimeDeskDays": 21, "reviewTimeDeskDisplay": "~21 days", "reviewTimeFirstDecisionDays": 56, "reviewTimeFirstDecisionDisplay": "6–10 weeks", "reviewTimeType": "estimated", "deskRejectRateDisplay": ">90%", "deskRejectRateType": "estimated", "submissionWordLimitDisplay": "~3,000", "abstractFormat": "Structured", "abstractWordLimitDisplay": "250", "figureLimitDisplay": "5 total", "referenceLimitDisplay": "70", "fitSignals": [ "the manuscript changes clinical practice rather than adding incremental evidence", "methods and interpretation can survive intense clinical scrutiny" ], "commonRejectionReasons": [ "important specialty result without broad practice consequence", "claims of clinical importance outrun the trial or cohort evidence" ], "editorialModelSummary": "NEJM is an extreme clinical filter focused on practice-changing consequence. Most competent clinical studies are rejected before full review.", "manusightsDifficultyScore": 99, "manusightsDifficultyBand": "extreme", "sourceConfidence": "mixed", "sourceCount": 4, "lastReviewedAt": "2026-03-30", "versionTag": "2026.03.30-mvp1" }, { "journalSlug": "lancet", "journalName": "The Lancet", "publisherName": "Elsevier", "fieldPrimary": "Clinical Medicine", "openAccessModel": "hybrid", "impactFactorDisplay": "88.5", "acceptanceRateDisplay": "<5%", "acceptanceRateType": "estimated", "reviewTimeDeskDays": 24, "reviewTimeDeskDisplay": "21–28 days", "reviewTimeFirstDecisionDays": 56, "reviewTimeFirstDecisionDisplay": "6–10 weeks", "reviewTimeType": "estimated", "deskRejectRateDisplay": ">90%", "deskRejectRateType": "estimated", "submissionWordLimitDisplay": "~3,000", "abstractFormat": "Unstructured summary", "abstractWordLimitDisplay": "150", "figureLimitDisplay": "5 total", "referenceLimitDisplay": "60", "fitSignals": [ "the paper matters across medicine or public health, not only a subspecialty", "the consequence is visible at policy or guideline level" ], "commonRejectionReasons": [ "good medicine without general-clinical reach", "regional or narrow impact presented as global consequence" ], "editorialModelSummary": "The Lancet screens hard for broad medical and policy consequence, not only study quality.", "manusightsDifficultyScore": 99, "manusightsDifficultyBand": "extreme", "sourceConfidence": "mixed", "sourceCount": 4, "lastReviewedAt": "2026-03-30", "versionTag": "2026.03.30-mvp1" }, { "journalSlug": "jama", "journalName": "JAMA", "publisherName": "American Medical Association", "fieldPrimary": "Clinical Medicine", "openAccessModel": "hybrid", "impactFactorDisplay": "55.0", "acceptanceRateDisplay": "<5%", "acceptanceRateType": "reported", "reviewTimeDeskDays": 18, "reviewTimeDeskDisplay": "2–3 weeks", "reviewTimeFirstDecisionDays": 49, "reviewTimeFirstDecisionDisplay": "6–8 weeks", "reviewTimeType": "estimated", "deskRejectRateDisplay": ">90%", "deskRejectRateType": "estimated", "submissionWordLimitDisplay": "~2,800", "abstractFormat": "Structured", "abstractWordLimitDisplay": "300", "figureLimitDisplay": "5 total", "referenceLimitDisplay": "35", "fitSignals": [ "clinical message is broad-interest and immediately legible", "evidence and framing both look disciplined to general medical editors" ], "commonRejectionReasons": [ "strong specialty work without general physician relevance", "overstated implications from exploratory or narrow data" ], "editorialModelSummary": "JAMA behaves as a general medical flagship and rejects many technically strong but too-specialized papers at editorial triage.", "manusightsDifficultyScore": 96, "manusightsDifficultyBand": "extreme", "sourceConfidence": "mixed", "sourceCount": 4, "lastReviewedAt": "2026-03-30", "versionTag": "2026.03.30-mvp1" }, { "journalSlug": "nature-medicine", "journalName": "Nature Medicine", "publisherName": "Springer Nature", "fieldPrimary": "Clinical Medicine", "openAccessModel": "hybrid", "impactFactorDisplay": "50.0", "acceptanceRateDisplay": "<8%", "acceptanceRateType": "estimated", "reviewTimeDeskDays": 30, "reviewTimeDeskDisplay": "~30 days", "reviewTimeFirstDecisionDays": 70, "reviewTimeFirstDecisionDisplay": "8–12 weeks", "reviewTimeType": "estimated", "deskRejectRateDisplay": ">85%", "deskRejectRateType": "estimated", "submissionWordLimitDisplay": "~3,000–5,000", "abstractFormat": "Unstructured", "abstractWordLimitDisplay": "150", "figureLimitDisplay": "6 display items", "referenceLimitDisplay": "60", "fitSignals": [ "translational or medical consequence is integral to the main story", "mechanistic strength and human relevance both carry weight" ], "commonRejectionReasons": [ "important preclinical work without enough translational force", "clinical relevance is asserted more than demonstrated" ], "editorialModelSummary": "Nature Medicine is a translational flagship that screens for direct medical importance, not just elegant biology.", "manusightsDifficultyScore": 94, "manusightsDifficultyBand": "extreme", "sourceConfidence": "mixed", "sourceCount": 4, "lastReviewedAt": "2026-03-30", "versionTag": "2026.03.30-mvp1" }, { "journalSlug": "nature-communications", "journalName": "Nature Communications", "publisherName": "Springer Nature", "fieldPrimary": "Multidisciplinary", "openAccessModel": "gold_oa", "impactFactorDisplay": "15.7", "acceptanceRateDisplay": "~20%", "acceptanceRateType": "estimated", "reviewTimeDeskDays": 9, "reviewTimeDeskDisplay": "~9 days", "reviewTimeFirstDecisionDays": 49, "reviewTimeFirstDecisionDisplay": "6–8 weeks", "reviewTimeType": "estimated", "deskRejectRateDisplay": "~50%", "deskRejectRateType": "estimated", "fitSignals": [ "the study is novel and complete even if not Nature-level broad", "scope is still wide enough for a large multidisciplinary OA venue" ], "commonRejectionReasons": [ "sound but too incremental for the venue's novelty bar", "good specialty paper without enough broader interest" ], "editorialModelSummary": "Nature Communications has a lower breadth threshold than flagship Nature titles but remains a real professional-editor novelty filter.", "manusightsDifficultyScore": 76, "manusightsDifficultyBand": "elite", "sourceConfidence": "mixed", "sourceCount": 4, "lastReviewedAt": "2026-03-30", "versionTag": "2026.03.30-mvp1" }, { "journalSlug": "cancer-cell", "journalName": "Cancer Cell", "publisherName": "Cell Press", "fieldPrimary": "Oncology", "openAccessModel": "hybrid", "impactFactorDisplay": "44.5", "acceptanceRateDisplay": "~8–10%", "acceptanceRateType": "estimated", "reviewTimeDeskDays": 5, "reviewTimeDeskDisplay": "~5 days", "reviewTimeFirstDecisionDays": 56, "reviewTimeFirstDecisionDisplay": "~8 weeks", "reviewTimeType": "estimated", "deskRejectRateDisplay": ">85%", "deskRejectRateType": "estimated", "submissionWordLimitDisplay": "~6,000–8,000", "abstractFormat": "Unstructured", "abstractWordLimitDisplay": "150", "figureLimitDisplay": "7 main figures", "referenceLimitDisplay": "100", "fitSignals": [ "oncology consequence and mechanistic depth are both clear", "the story changes how cancer biologists think, not just one disease niche" ], "commonRejectionReasons": [ "disease relevance without enough conceptual or mechanistic lift", "translational excitement unsupported by the evidence package" ], "editorialModelSummary": "Cancer Cell is a fast-triage oncology flagship that expects both conceptual depth and real cancer consequence.", "manusightsDifficultyScore": 93, "manusightsDifficultyBand": "extreme", "sourceConfidence": "mixed", "sourceCount": 4, "lastReviewedAt": "2026-03-30", "versionTag": "2026.03.30-mvp1" }, { "journalSlug": "journal-of-clinical-oncology", "journalName": "Journal of Clinical Oncology", "publisherName": "ASCO", "fieldPrimary": "Oncology", "openAccessModel": "hybrid", "impactFactorDisplay": "41.9", "acceptanceRateDisplay": "~15%", "acceptanceRateType": "estimated", "reviewTimeDeskDays": 30, "reviewTimeDeskDisplay": "~30 days", "reviewTimeFirstDecisionDays": 49, "reviewTimeFirstDecisionDisplay": "6–8 weeks", "reviewTimeType": "estimated", "deskRejectRateDisplay": "~70%", "deskRejectRateType": "estimated", "submissionWordLimitDisplay": "~4,000", "abstractFormat": "Structured", "abstractWordLimitDisplay": "250", "figureLimitDisplay": "5 total", "referenceLimitDisplay": "60", "fitSignals": [ "clinical relevance is strong enough to matter to oncologists broadly", "the manuscript is framed around practice or care implications" ], "commonRejectionReasons": [ "good oncology data without enough field-wide clinical consequence", "specialty-only impact better suited to a narrower journal" ], "editorialModelSummary": "JCO is selective but more clinically practical than oncology flagships, rewarding papers that matter directly to oncology practice.", "manusightsDifficultyScore": 82, "manusightsDifficultyBand": "extreme", "sourceConfidence": "mixed", "sourceCount": 4, "lastReviewedAt": "2026-03-30", "versionTag": "2026.03.30-mvp1" }, { "journalSlug": "circulation", "journalName": "Circulation", "publisherName": "American Heart Association", "fieldPrimary": "Cardiology", "openAccessModel": "hybrid", "impactFactorDisplay": "38.6", "acceptanceRateDisplay": "~7%", "acceptanceRateType": "estimated", "reviewTimeDeskDays": 7, "reviewTimeDeskDisplay": "~7 days", "reviewTimeFirstDecisionDays": 35, "reviewTimeFirstDecisionDisplay": "4–6 weeks", "reviewTimeType": "estimated", "deskRejectRateDisplay": "~70%", "deskRejectRateType": "estimated", "submissionWordLimitDisplay": "~4,000", "abstractFormat": "Structured", "abstractWordLimitDisplay": "250", "figureLimitDisplay": "6 total", "referenceLimitDisplay": "75", "fitSignals": [ "cardiovascular consequence is broad and timely", "the story justifies flagship-cardiology positioning" ], "commonRejectionReasons": [ "incremental cardiovascular advance", "subspecialty result without enough broad cardiology consequence" ], "editorialModelSummary": "Circulation combines fast triage with a flagship-cardiology significance bar and quickly filters out narrow work.", "manusightsDifficultyScore": 84, "manusightsDifficultyBand": "extreme", "sourceConfidence": "mixed", "sourceCount": 4, "lastReviewedAt": "2026-03-30", "versionTag": "2026.03.30-mvp1" }, { "journalSlug": "european-heart-journal", "journalName": "European Heart Journal", "publisherName": "Oxford University Press / ESC", "fieldPrimary": "Cardiology", "openAccessModel": "hybrid", "impactFactorDisplay": "35.6", "acceptanceRateDisplay": "~10%", "acceptanceRateType": "estimated", "reviewTimeDeskDays": 10, "reviewTimeDeskDisplay": "~10 days", "reviewTimeFirstDecisionDays": 35, "reviewTimeFirstDecisionDisplay": "4–6 weeks", "reviewTimeType": "estimated", "deskRejectRateDisplay": "~75%", "deskRejectRateType": "estimated", "submissionWordLimitDisplay": "~4,000", "abstractFormat": "Structured", "abstractWordLimitDisplay": "250", "figureLimitDisplay": "6 total", "referenceLimitDisplay": "50", "fitSignals": [ "cardiology-wide relevance is obvious from the first screen", "the paper has enough consequence to justify flagship society-journal positioning" ], "commonRejectionReasons": [ "solid cardiovascular work that is too narrow for a flagship audience", "specialist significance presented as field-wide importance" ], "editorialModelSummary": "EHJ is a flagship cardiology venue with rapid triage and a broad-cardiology significance bar.", "manusightsDifficultyScore": 82, "manusightsDifficultyBand": "extreme", "sourceConfidence": "mixed", "sourceCount": 4, "lastReviewedAt": "2026-03-30", "versionTag": "2026.03.30-mvp1" }, { "journalSlug": "jacc", "journalName": "JACC", "publisherName": "American College of Cardiology", "fieldPrimary": "Cardiology", "openAccessModel": "hybrid", "impactFactorDisplay": "22.3", "acceptanceRateDisplay": "~5%", "acceptanceRateType": "estimated", "reviewTimeDeskDays": 18, "reviewTimeDeskDisplay": "14–21 days", "reviewTimeFirstDecisionDays": 35, "reviewTimeFirstDecisionDisplay": "4–6 weeks", "reviewTimeType": "estimated", "deskRejectRateDisplay": ">85%", "deskRejectRateType": "estimated", "submissionWordLimitDisplay": "~5,000", "abstractFormat": "Structured", "abstractWordLimitDisplay": "300", "figureLimitDisplay": "7 total", "referenceLimitDisplay": "100", "fitSignals": [ "the study matters to practicing cardiologists at a broad level", "clinical or translational force is clear enough for a premier society journal" ], "commonRejectionReasons": [ "good cardiovascular research without enough flagship consequence", "overly narrow subfield appeal for a broad cardiology readership" ], "editorialModelSummary": "JACC is highly selective and screens first for broad cardiovascular importance and clinical consequence.", "manusightsDifficultyScore": 85, "manusightsDifficultyBand": "extreme", "sourceConfidence": "mixed", "sourceCount": 4, "lastReviewedAt": "2026-03-30", "versionTag": "2026.03.30-mvp1" }, { "journalSlug": "blood", "journalName": "Blood", "publisherName": "American Society of Hematology", "fieldPrimary": "Clinical Medicine", "openAccessModel": "hybrid", "impactFactorDisplay": "23.1", "acceptanceRateDisplay": "~20%", "acceptanceRateType": "estimated", "reviewTimeDeskDays": 30, "reviewTimeDeskDisplay": "~30 days", "reviewTimeFirstDecisionDays": 49, "reviewTimeFirstDecisionDisplay": "6–8 weeks", "reviewTimeType": "estimated", "deskRejectRateDisplay": "~60%", "deskRejectRateType": "estimated", "fitSignals": [ "hematology relevance is broad and not limited to one narrow disease niche", "the paper is rigorous enough for a flagship society journal even if not NEJM-tier" ], "commonRejectionReasons": [ "narrow hematology story without enough field-wide importance", "good data but not enough novelty or practice consequence for Blood" ], "editorialModelSummary": "Blood is a flagship hematology journal with a meaningful but not impossible selectivity bar, rewarding studies that matter broadly across hematology.", "manusightsDifficultyScore": 72, "manusightsDifficultyBand": "elite", "sourceConfidence": "mixed", "sourceCount": 3, "lastReviewedAt": "2026-03-30", "versionTag": "2026.03.30-mvp1" }, { "journalSlug": "jci", "journalName": "Journal of Clinical Investigation", "publisherName": "American Society for Clinical Investigation", "fieldPrimary": "Clinical Medicine", "openAccessModel": "hybrid", "impactFactorDisplay": "13.6", "acceptanceRateDisplay": "~8–10%", "acceptanceRateType": "estimated", "reviewTimeDeskDays": 21, "reviewTimeDeskDisplay": "2–4 weeks", "reviewTimeFirstDecisionDays": 56, "reviewTimeFirstDecisionDisplay": "6–10 weeks", "reviewTimeType": "estimated", "deskRejectRateDisplay": "~70%", "deskRejectRateType": "estimated", "fitSignals": [ "mechanistic disease relevance is strong enough to matter clinically", "the manuscript connects biology and disease convincingly" ], "commonRejectionReasons": [ "good mechanism without enough disease consequence", "clinical framing that is weaker than the underlying basic science" ], "editorialModelSummary": "JCI values disease-oriented mechanistic work and filters out papers that are either too basic for disease relevance or too clinical for mechanistic depth.", "manusightsDifficultyScore": 74, "manusightsDifficultyBand": "elite", "sourceConfidence": "mixed", "sourceCount": 3, "lastReviewedAt": "2026-03-30", "versionTag": "2026.03.30-mvp1" }, { "journalSlug": "jama-oncology", "journalName": "JAMA Oncology", "publisherName": "American Medical Association", "fieldPrimary": "Oncology", "openAccessModel": "hybrid", "impactFactorDisplay": "20.1", "acceptanceRateDisplay": "~8%", "acceptanceRateType": "estimated", "reviewTimeDeskDays": 21, "reviewTimeDeskDisplay": "~21 days", "reviewTimeFirstDecisionDays": 49, "reviewTimeFirstDecisionDisplay": "6–8 weeks", "reviewTimeType": "estimated", "deskRejectRateDisplay": ">85%", "deskRejectRateType": "estimated", "submissionWordLimitDisplay": "~2,800", "abstractFormat": "Structured", "abstractWordLimitDisplay": "300", "figureLimitDisplay": "5 total", "referenceLimitDisplay": "35", "fitSignals": [ "the manuscript has clear oncology-practice relevance", "the framing is broad enough for a top network oncology title" ], "commonRejectionReasons": [ "strong oncology data without enough broad clinical consequence", "specialty significance that is better suited to a narrower oncology journal" ], "editorialModelSummary": "JAMA Oncology screens for broad oncology relevance and rejects many technically solid but more limited specialty papers.", "manusightsDifficultyScore": 83, "manusightsDifficultyBand": "extreme", "sourceConfidence": "mixed", "sourceCount": 4, "lastReviewedAt": "2026-03-30", "versionTag": "2026.03.30-mvp1" }, { "journalSlug": "lancet-oncology", "journalName": "The Lancet Oncology", "publisherName": "Elsevier", "fieldPrimary": "Oncology", "openAccessModel": "hybrid", "impactFactorDisplay": "35.9", "acceptanceRateDisplay": "~8%", "acceptanceRateType": "estimated", "reviewTimeDeskDays": 14, "reviewTimeDeskDisplay": "~14 days", "reviewTimeFirstDecisionDays": 35, "reviewTimeFirstDecisionDisplay": "4–6 weeks", "reviewTimeType": "estimated", "deskRejectRateDisplay": ">85%", "deskRejectRateType": "estimated", "submissionWordLimitDisplay": "~3,000", "abstractFormat": "Structured", "abstractWordLimitDisplay": "250", "figureLimitDisplay": "5 total", "referenceLimitDisplay": "60", "fitSignals": [ "oncology consequence is broad enough to matter outside one tumor niche", "the paper has clear practice, policy, or guideline relevance" ], "commonRejectionReasons": [ "important oncology result without enough general oncology significance", "solid trial or translational data that does not justify Lancet-family reach" ], "editorialModelSummary": "Lancet Oncology is a fast-triage oncology flagship prioritizing broad oncology and clinical consequence over narrower specialty impact.", "manusightsDifficultyScore": 91, "manusightsDifficultyBand": "extreme", "sourceConfidence": "mixed", "sourceCount": 4, "lastReviewedAt": "2026-03-30", "versionTag": "2026.03.30-mvp1" }, { "journalSlug": "nature-biotechnology", "journalName": "Nature Biotechnology", "publisherName": "Springer Nature", "fieldPrimary": "Genomics & Methods", "openAccessModel": "hybrid", "impactFactorDisplay": "41.7", "acceptanceRateDisplay": "<10%", "acceptanceRateType": "estimated", "reviewTimeDeskDays": 4, "reviewTimeDeskDisplay": "~4 days", "reviewTimeFirstDecisionDays": 49, "reviewTimeFirstDecisionDisplay": "6–8 weeks", "reviewTimeType": "estimated", "deskRejectRateDisplay": ">85%", "deskRejectRateType": "estimated", "fitSignals": [ "the platform matters beyond one use case", "benchmarking proves field-level or translational advantage" ], "commonRejectionReasons": [ "interesting method without broad platform consequence", "technical novelty that does not translate into real biotechnology leverage" ], "editorialModelSummary": "Nature Biotechnology screens extremely fast for platform consequence and broad translational or field impact.", "manusightsDifficultyScore": 94, "manusightsDifficultyBand": "extreme", "sourceConfidence": "mixed", "sourceCount": 3, "lastReviewedAt": "2026-03-30", "versionTag": "2026.03.30-mvp1" }, { "journalSlug": "nature-methods", "journalName": "Nature Methods", "publisherName": "Springer Nature", "fieldPrimary": "Genomics & Methods", "openAccessModel": "hybrid", "impactFactorDisplay": "32.1", "acceptanceRateDisplay": "~8–10%", "acceptanceRateType": "estimated", "reviewTimeDeskDays": 7, "reviewTimeDeskDisplay": "~7 days", "reviewTimeFirstDecisionDays": 49, "reviewTimeFirstDecisionDisplay": "6–8 weeks", "reviewTimeType": "estimated", "deskRejectRateDisplay": ">85%", "deskRejectRateType": "estimated", "fitSignals": [ "the method changes what many labs can do, not just one narrow workflow", "benchmarking is strong enough to justify flagship methods positioning" ], "commonRejectionReasons": [ "clever but narrow method with limited adoption potential", "weak benchmarking against the real current standard" ], "editorialModelSummary": "Nature Methods filters for generalizable technical advances and quickly rejects narrowly useful or weakly benchmarked methods papers.", "manusightsDifficultyScore": 92, "manusightsDifficultyBand": "extreme", "sourceConfidence": "mixed", "sourceCount": 3, "lastReviewedAt": "2026-03-30", "versionTag": "2026.03.30-mvp1" }, { "journalSlug": "nature-genetics", "journalName": "Nature Genetics", "publisherName": "Springer Nature", "fieldPrimary": "Genomics & Methods", "openAccessModel": "hybrid", "impactFactorDisplay": "29.0", "acceptanceRateDisplay": "<10%", "acceptanceRateType": "estimated", "reviewTimeDeskDays": 30, "reviewTimeDeskDisplay": "~30 days", "reviewTimeFirstDecisionDays": 70, "reviewTimeFirstDecisionDisplay": "8–12 weeks", "reviewTimeType": "estimated", "deskRejectRateDisplay": ">85%", "deskRejectRateType": "estimated", "fitSignals": [ "the genetics advance is broadly important beyond one cohort or locus", "the work changes how the field thinks about a biological or disease question" ], "commonRejectionReasons": [ "good genomics data without enough conceptual lift", "cohort or association story that feels too incremental for flagship genetics" ], "editorialModelSummary": "Nature Genetics is a flagship genetics filter prioritizing broad conceptual significance over merely large or technically competent datasets.", "manusightsDifficultyScore": 90, "manusightsDifficultyBand": "extreme", "sourceConfidence": "mixed", "sourceCount": 3, "lastReviewedAt": "2026-03-30", "versionTag": "2026.03.30-mvp1" }, { "journalSlug": "nature-immunology", "journalName": "Nature Immunology", "publisherName": "Springer Nature", "fieldPrimary": "Immunology", "openAccessModel": "hybrid", "impactFactorDisplay": "27.6", "acceptanceRateDisplay": "~5–8%", "acceptanceRateType": "estimated", "reviewTimeDeskDays": 5, "reviewTimeDeskDisplay": "~5 days", "reviewTimeFirstDecisionDays": 56, "reviewTimeFirstDecisionDisplay": "6–10 weeks", "reviewTimeType": "estimated", "deskRejectRateDisplay": ">90%", "deskRejectRateType": "estimated", "fitSignals": [ "the immune mechanism is both sharp and broadly field-shaping", "the conceptual lift is obvious from the first read" ], "commonRejectionReasons": [ "important immunology result without enough flagship-level conceptual reach", "mechanistic story that still feels one major step short" ], "editorialModelSummary": "Nature Immunology triages very fast and rewards broad conceptual immunology, not just excellent specialty work.", "manusightsDifficultyScore": 91, "manusightsDifficultyBand": "extreme", "sourceConfidence": "mixed", "sourceCount": 3, "lastReviewedAt": "2026-03-30", "versionTag": "2026.03.30-mvp1" }, { "journalSlug": "cell-metabolism", "journalName": "Cell Metabolism", "publisherName": "Cell Press", "fieldPrimary": "Cell & Molecular Biology", "openAccessModel": "hybrid", "impactFactorDisplay": "30.9", "acceptanceRateDisplay": "~5–8%", "acceptanceRateType": "estimated", "reviewTimeDeskDays": 5, "reviewTimeDeskDisplay": "3–7 days", "reviewTimeFirstDecisionDays": 63, "reviewTimeFirstDecisionDisplay": "9–10 weeks", "reviewTimeType": "estimated", "deskRejectRateDisplay": ">80%", "deskRejectRateType": "estimated", "fitSignals": [ "metabolic consequence and mechanistic depth are both strong", "the paper matters broadly across metabolism, not one assay niche" ], "commonRejectionReasons": [ "important physiology without enough mechanistic closure", "good metabolism story that is too narrow for the journal's breadth bar" ], "editorialModelSummary": "Cell Metabolism behaves like a metabolism flagship that expects both conceptual breadth and strong mechanistic support.", "manusightsDifficultyScore": 88, "manusightsDifficultyBand": "extreme", "sourceConfidence": "mixed", "sourceCount": 3, "lastReviewedAt": "2026-03-30", "versionTag": "2026.03.30-mvp1" }, { "journalSlug": "cell-reports", "journalName": "Cell Reports", "publisherName": "Cell Press", "fieldPrimary": "Cell & Molecular Biology", "openAccessModel": "gold_oa", "impactFactorDisplay": "6.9", "acceptanceRateDisplay": "~15–20%", "acceptanceRateType": "estimated", "reviewTimeDeskDays": 5, "reviewTimeDeskDisplay": "~5 days", "reviewTimeFirstDecisionDays": 42, "reviewTimeFirstDecisionDisplay": "5–7 weeks", "reviewTimeType": "estimated", "deskRejectRateDisplay": "~50%", "deskRejectRateType": "estimated", "fitSignals": [ "the study is complete and biologically useful even if not Cell-level broad", "the story is mechanistically coherent and decision-ready" ], "commonRejectionReasons": [ "incremental story without enough novelty even for the tier-2 level", "solid result that still looks incomplete" ], "editorialModelSummary": "Cell Reports is a broad Cell Press OA venue with fast triage and a real completeness bar, but a lower breadth threshold than flagship Cell.", "manusightsDifficultyScore": 63, "manusightsDifficultyBand": "elite", "sourceConfidence": "mixed", "sourceCount": 3, "lastReviewedAt": "2026-03-30", "versionTag": "2026.03.30-mvp1" }, { "journalSlug": "molecular-cell", "journalName": "Molecular Cell", "publisherName": "Cell Press", "fieldPrimary": "Cell & Molecular Biology", "openAccessModel": "hybrid", "impactFactorDisplay": "16.6", "acceptanceRateDisplay": "~13%", "acceptanceRateType": "estimated", "reviewTimeDeskDays": 4, "reviewTimeDeskDisplay": "3–5 days", "reviewTimeFirstDecisionDays": 28, "reviewTimeFirstDecisionDisplay": "3–4 weeks", "reviewTimeType": "estimated", "deskRejectRateDisplay": "~60%", "deskRejectRateType": "estimated", "fitSignals": [ "mechanistic novelty is strong enough to matter beyond one narrow niche", "the paper changes how a molecular process is understood" ], "commonRejectionReasons": [ "good molecular mechanism without enough conceptual breadth", "specialist depth that feels too narrow for the journal's scope" ], "editorialModelSummary": "Molecular Cell values mechanistic depth plus conceptual reach and is more selective than specialty molecular journals but less broad than Cell.", "manusightsDifficultyScore": 79, "manusightsDifficultyBand": "elite", "sourceConfidence": "mixed", "sourceCount": 3, "lastReviewedAt": "2026-03-30", "versionTag": "2026.03.30-mvp1" }, { "journalSlug": "neuron", "journalName": "Neuron", "publisherName": "Cell Press", "fieldPrimary": "Neuroscience", "openAccessModel": "hybrid", "impactFactorDisplay": "15.0", "acceptanceRateDisplay": "~8%", "acceptanceRateType": "estimated", "reviewTimeDeskDays": 4, "reviewTimeDeskDisplay": "3–5 days", "reviewTimeFirstDecisionDays": 35, "reviewTimeFirstDecisionDisplay": "4–5 weeks", "reviewTimeType": "estimated", "deskRejectRateDisplay": "~75%", "deskRejectRateType": "estimated", "fitSignals": [ "the neuroscience consequence is broad and conceptually strong", "the story survives beyond one model system or one narrow circuit niche" ], "commonRejectionReasons": [ "good neuroscience without enough broad conceptual reach", "important phenotype with insufficient mechanistic support" ], "editorialModelSummary": "Neuron triages very quickly and rewards broad, conceptually important neuroscience rather than narrow subfield advances.", "manusightsDifficultyScore": 86, "manusightsDifficultyBand": "extreme", "sourceConfidence": "mixed", "sourceCount": 3, "lastReviewedAt": "2026-03-30", "versionTag": "2026.03.30-mvp1" }, { "journalSlug": "nucleic-acids-research", "journalName": "Nucleic Acids Research", "publisherName": "Oxford University Press", "fieldPrimary": "Genomics & Methods", "openAccessModel": "gold_oa", "impactFactorDisplay": "13.1", "acceptanceRateDisplay": "~45%", "acceptanceRateType": "estimated", "reviewTimeDeskDays": 45, "reviewTimeDeskDisplay": "~45 days total", "reviewTimeFirstDecisionDays": 56, "reviewTimeFirstDecisionDisplay": "6–10 weeks", "reviewTimeType": "estimated", "deskRejectRateDisplay": "~40%", "deskRejectRateType": "estimated", "fitSignals": [ "the paper fits a strong NAR lane such as methods, databases, or nucleic-acid biology", "the manuscript is practical and well documented enough for a resource- and methods-friendly venue" ], "commonRejectionReasons": [ "research article framed as more general than the journal's strongest lanes support", "resource or methods paper without enough utility or documentation" ], "editorialModelSummary": "NAR is more accessible than flagship genetics or methods venues, especially for strong methods and resource papers, but still expects clear utility and good fit to its strongest editorial lanes.", "manusightsDifficultyScore": 58, "manusightsDifficultyBand": "selective", "sourceConfidence": "mixed", "sourceCount": 3, "lastReviewedAt": "2026-03-30", "versionTag": "2026.03.30-mvp1" }, { "journalSlug": "bmj", "journalName": "The BMJ", "publisherName": "BMJ", "fieldPrimary": "Clinical Medicine", "openAccessModel": "hybrid", "impactFactorDisplay": "42.7", "acceptanceRateDisplay": "~7% overall; ~4% research", "acceptanceRateType": "reported", "reviewTimeDeskDays": 14, "reviewTimeDeskDisplay": "Days to 2 weeks", "reviewTimeFirstDecisionDays": 48, "reviewTimeFirstDecisionDisplay": "~48 days with review", "reviewTimeType": "reported", "deskRejectRateDisplay": ">85%", "deskRejectRateType": "estimated", "submissionWordLimitDisplay": "~3,400", "abstractFormat": "Structured", "abstractWordLimitDisplay": "300", "figureLimitDisplay": "6 total", "referenceLimitDisplay": "40", "fitSignals": [ "the paper has broad general-medical or public-health value", "methods and reporting are strong enough for a flagship general medical readership" ], "commonRejectionReasons": [ "good clinical paper without enough broad BMJ-level consequence", "strong specialty study framed too narrowly for a general medical venue" ], "editorialModelSummary": "The BMJ is a general medical flagship with strong reporting expectations and a high bar for broad clinical consequence.", "manusightsDifficultyScore": 90, "manusightsDifficultyBand": "extreme", "sourceConfidence": "mixed", "sourceCount": 4, "lastReviewedAt": "2026-03-30", "versionTag": "2026.03.30-mvp1" }, { "journalSlug": "bmj-open", "journalName": "BMJ Open", "publisherName": "BMJ", "fieldPrimary": "Clinical Medicine", "openAccessModel": "gold_oa", "impactFactorDisplay": "2.3", "acceptanceRateDisplay": "~27%", "acceptanceRateType": "estimated", "reviewTimeDeskDays": 134, "reviewTimeDeskDisplay": "~134 days total", "reviewTimeFirstDecisionDays": 126, "reviewTimeFirstDecisionDisplay": "16–20 weeks", "reviewTimeType": "reported", "deskRejectRateDisplay": "~30%", "deskRejectRateType": "estimated", "fitSignals": [ "the paper is sound, well reported, and appropriate for a broad clinical OA venue", "the team is prioritizing rigor and accessibility over prestige filtering" ], "commonRejectionReasons": [ "methods or reporting weaknesses that fail a soundness-first review model", "scope mismatch or unclear manuscript value despite adequate methods" ], "editorialModelSummary": "BMJ Open is a broad soundness-oriented clinical OA journal with slower timelines and a lower novelty threshold than BMJ.", "manusightsDifficultyScore": 36, "manusightsDifficultyBand": "accessible", "sourceConfidence": "medium", "sourceCount": 3, "lastReviewedAt": "2026-03-30", "versionTag": "2026.03.30-mvp1" }, { "journalSlug": "bmc-medicine", "journalName": "BMC Medicine", "publisherName": "Springer Nature / BMC", "fieldPrimary": "Clinical Medicine", "openAccessModel": "gold_oa", "impactFactorDisplay": "8.3", "acceptanceRateDisplay": "~20%", "acceptanceRateType": "estimated", "reviewTimeDeskDays": 38, "reviewTimeDeskDisplay": "30–45 days total", "reviewTimeFirstDecisionDays": 70, "reviewTimeFirstDecisionDisplay": "8–12 weeks", "reviewTimeType": "estimated", "deskRejectRateDisplay": "~45%", "deskRejectRateType": "estimated", "fitSignals": [ "the paper is clinically relevant and broad enough for a serious general-medicine OA venue", "the work has wider interest even if not BMJ or JAMA tier" ], "commonRejectionReasons": [ "clinical study too narrow for a general-medicine readership", "solid study with insufficient lift for a flagship OA medicine journal" ], "editorialModelSummary": "BMC Medicine is a general-medicine OA journal with real selectivity but a lower consequence bar than top medical flagships.", "manusightsDifficultyScore": 57, "manusightsDifficultyBand": "selective", "sourceConfidence": "mixed", "sourceCount": 3, "lastReviewedAt": "2026-03-30", "versionTag": "2026.03.30-mvp1" }, { "journalSlug": "gastroenterology", "journalName": "Gastroenterology", "publisherName": "AGA / Elsevier", "fieldPrimary": "Clinical Medicine", "openAccessModel": "hybrid", "impactFactorDisplay": "25.1", "acceptanceRateDisplay": "~12%", "acceptanceRateType": "estimated", "reviewTimeDeskDays": 14, "reviewTimeDeskDisplay": "~14 days", "reviewTimeFirstDecisionDays": 42, "reviewTimeFirstDecisionDisplay": "5–7 weeks", "reviewTimeType": "estimated", "deskRejectRateDisplay": "~70%", "deskRejectRateType": "estimated", "fitSignals": [ "the paper matters broadly across GI rather than one narrow disease lane", "mechanistic or clinical relevance is strong enough for a flagship specialty journal" ], "commonRejectionReasons": [ "good GI work that is too narrow or incremental for flagship specialty treatment", "important result without enough breadth for the journal's readership" ], "editorialModelSummary": "Gastroenterology is a flagship GI journal with fairly fast triage and a meaningful breadth bar inside the specialty.", "manusightsDifficultyScore": 76, "manusightsDifficultyBand": "elite", "sourceConfidence": "mixed", "sourceCount": 3, "lastReviewedAt": "2026-03-30", "versionTag": "2026.03.30-mvp1" }, { "journalSlug": "gut", "journalName": "GUT", "publisherName": "BMJ", "fieldPrimary": "Clinical Medicine", "openAccessModel": "hybrid", "impactFactorDisplay": "25.8", "acceptanceRateDisplay": "~12%", "acceptanceRateType": "estimated", "reviewTimeDeskDays": 14, "reviewTimeDeskDisplay": "~14 days", "reviewTimeFirstDecisionDays": 35, "reviewTimeFirstDecisionDisplay": "~5 weeks", "reviewTimeType": "estimated", "deskRejectRateDisplay": "~70%", "deskRejectRateType": "estimated", "fitSignals": [ "the paper has broad GI or hepatology relevance and strong execution", "the advance is important enough to matter across the specialty" ], "commonRejectionReasons": [ "well-done GI study without enough flagship-specialty consequence", "too narrow a subfield story for the journal's broad readership" ], "editorialModelSummary": "GUT is a selective BMJ specialty flagship that filters for broadly important gastroenterology and hepatology work.", "manusightsDifficultyScore": 77, "manusightsDifficultyBand": "elite", "sourceConfidence": "mixed", "sourceCount": 3, "lastReviewedAt": "2026-03-30", "versionTag": "2026.03.30-mvp1" }, { "journalSlug": "hepatology", "journalName": "Hepatology", "publisherName": "AASLD / Wiley", "fieldPrimary": "Clinical Medicine", "openAccessModel": "hybrid", "impactFactorDisplay": "15.8", "acceptanceRateDisplay": "~15%", "acceptanceRateType": "estimated", "reviewTimeDeskDays": 30, "reviewTimeDeskDisplay": "~30 days", "reviewTimeFirstDecisionDays": 49, "reviewTimeFirstDecisionDisplay": "6–8 weeks", "reviewTimeType": "estimated", "deskRejectRateDisplay": "~65%", "deskRejectRateType": "estimated", "fitSignals": [ "the paper matters to hepatology broadly rather than a single liver niche", "clinical or mechanistic relevance is clear enough for a specialty flagship" ], "commonRejectionReasons": [ "good liver-focused study without enough broad specialty consequence", "solid data but not enough selectivity-level novelty or importance" ], "editorialModelSummary": "Hepatology is a flagship liver journal with meaningful selectivity but a more accessible bar than general medical flagships.", "manusightsDifficultyScore": 69, "manusightsDifficultyBand": "elite", "sourceConfidence": "mixed", "sourceCount": 3, "lastReviewedAt": "2026-03-30", "versionTag": "2026.03.30-mvp1" }, { "journalSlug": "immunity", "journalName": "Immunity", "publisherName": "Cell Press", "fieldPrimary": "Immunology", "openAccessModel": "hybrid", "impactFactorDisplay": "26.3", "acceptanceRateDisplay": "~8–10%", "acceptanceRateType": "estimated", "reviewTimeDeskDays": 4, "reviewTimeDeskDisplay": "3–5 days", "reviewTimeFirstDecisionDays": 28, "reviewTimeFirstDecisionDisplay": "3–4 weeks", "reviewTimeType": "estimated", "deskRejectRateDisplay": "~75%", "deskRejectRateType": "estimated", "fitSignals": [ "the immune mechanism is broad, clear, and conceptually important", "the study changes how immunologists think about a real question" ], "commonRejectionReasons": [ "good immunology without enough conceptual breadth", "important phenotype but insufficient mechanistic closure" ], "editorialModelSummary": "Immunity triages extremely fast and prizes broad conceptual immunology rather than narrow specialist advances.", "manusightsDifficultyScore": 88, "manusightsDifficultyBand": "extreme", "sourceConfidence": "mixed", "sourceCount": 3, "lastReviewedAt": "2026-03-30", "versionTag": "2026.03.30-mvp1" }, { "journalSlug": "genome-biology", "journalName": "Genome Biology", "publisherName": "Springer Nature / BMC", "fieldPrimary": "Genomics & Methods", "openAccessModel": "gold_oa", "impactFactorDisplay": "9.4", "acceptanceRateDisplay": "~15%", "acceptanceRateType": "estimated", "reviewTimeDeskDays": 38, "reviewTimeDeskDisplay": "30–45 days total", "reviewTimeFirstDecisionDays": 70, "reviewTimeFirstDecisionDisplay": "8–12 weeks", "reviewTimeType": "estimated", "deskRejectRateDisplay": "~55%", "deskRejectRateType": "estimated", "fitSignals": [ "the genomics contribution is broadly useful and not just dataset-sized", "methods, benchmarking, or biological insight are strong enough for a leading OA genomics venue" ], "commonRejectionReasons": [ "large genomics paper without enough conceptual or practical lift", "resource or methods angle is weaker than the journal's best lanes require" ], "editorialModelSummary": "Genome Biology is a strong OA genomics venue that remains selective on utility, conceptual lift, and field-wide value.", "manusightsDifficultyScore": 66, "manusightsDifficultyBand": "elite", "sourceConfidence": "mixed", "sourceCount": 3, "lastReviewedAt": "2026-03-30", "versionTag": "2026.03.30-mvp1" }, { "journalSlug": "pnas", "journalName": "PNAS", "publisherName": "National Academy of Sciences", "fieldPrimary": "Multidisciplinary", "openAccessModel": "hybrid", "impactFactorDisplay": "9.1", "acceptanceRateDisplay": "~15%", "acceptanceRateType": "estimated", "reviewTimeDeskDays": 45, "reviewTimeDeskDisplay": "~45 days total", "reviewTimeFirstDecisionDays": 56, "reviewTimeFirstDecisionDisplay": "6–8 weeks", "reviewTimeType": "estimated", "deskRejectRateDisplay": "~50%", "deskRejectRateType": "estimated", "fitSignals": [ "the paper has broad enough scientific interest for a general-science venue without needing Nature/Science-level reach", "the story is important beyond one subfield but still realistic for PNAS" ], "commonRejectionReasons": [ "specialist work that never escapes its disciplinary silo", "broad framing that is not matched by the underlying consequence" ], "editorialModelSummary": "PNAS sits below Nature and Science in breadth selectivity but still expects clear cross-field importance rather than purely specialist merit.", "manusightsDifficultyScore": 71, "manusightsDifficultyBand": "elite", "sourceConfidence": "mixed", "sourceCount": 3, "lastReviewedAt": "2026-03-30", "versionTag": "2026.03.30-mvp1" }, { "journalSlug": "science-advances", "journalName": "Science Advances", "publisherName": "AAAS", "fieldPrimary": "Multidisciplinary", "openAccessModel": "gold_oa", "impactFactorDisplay": "12.5", "acceptanceRateDisplay": "~10%", "acceptanceRateType": "estimated", "reviewTimeDeskDays": 14, "reviewTimeDeskDisplay": "1–3 weeks", "reviewTimeFirstDecisionDays": 56, "reviewTimeFirstDecisionDisplay": "6–10 weeks", "reviewTimeType": "estimated", "deskRejectRateDisplay": "~60%", "deskRejectRateType": "estimated", "fitSignals": [ "the paper has broad scientific interest without needing Science-level field-shifting force", "the story is strong, technically clean, and general enough for a high-end OA multidisciplinary venue" ], "commonRejectionReasons": [ "specialist work without enough broad readership value", "sound study that still does not clear the journal's novelty bar" ], "editorialModelSummary": "Science Advances is a selective AAAS OA venue with a lower breadth bar than Science but still a real general-science filter.", "manusightsDifficultyScore": 73, "manusightsDifficultyBand": "elite", "sourceConfidence": "mixed", "sourceCount": 3, "lastReviewedAt": "2026-03-30", "versionTag": "2026.03.30-mvp1" }, { "journalSlug": "brain", "journalName": "Brain", "publisherName": "Oxford University Press", "fieldPrimary": "Neuroscience", "openAccessModel": "hybrid", "impactFactorDisplay": "11.7", "acceptanceRateDisplay": "~15%", "acceptanceRateType": "estimated", "reviewTimeDeskDays": 49, "reviewTimeDeskDisplay": "6–8 weeks total", "reviewTimeFirstDecisionDays": 84, "reviewTimeFirstDecisionDisplay": "10–14 weeks", "reviewTimeType": "estimated", "deskRejectRateDisplay": "~65%", "deskRejectRateType": "estimated", "submissionWordLimitDisplay": "~4,000", "abstractFormat": "Unstructured", "abstractWordLimitDisplay": "250", "figureLimitDisplay": "6 total", "referenceLimitDisplay": "60", "fitSignals": [ "the paper has real clinical-neurology or translational consequence rather than only a narrow mechanistic result", "the evidence package is careful enough to survive a slower, more thorough editorial process" ], "commonRejectionReasons": [ "solid neuroscience without enough clinical or translational consequence for Brain", "claims of disease relevance outrun what the data actually establish" ], "editorialModelSummary": "Brain is a selective clinical-neuroscience journal that tolerates slower timelines in exchange for rigorous editorial screening and broad neurologic relevance.", "manusightsDifficultyScore": 68, "manusightsDifficultyBand": "elite", "sourceConfidence": "mixed", "sourceCount": 3, "lastReviewedAt": "2026-03-30", "versionTag": "2026.03.30-mvp1" }, { "journalSlug": "cell-host-microbe", "journalName": "Cell Host & Microbe", "publisherName": "Cell Press", "fieldPrimary": "Microbiology", "openAccessModel": "hybrid", "impactFactorDisplay": "18.7", "acceptanceRateDisplay": "~12%", "acceptanceRateType": "estimated", "reviewTimeDeskDays": 38, "reviewTimeDeskDisplay": "30–45 days total", "reviewTimeFirstDecisionDays": 63, "reviewTimeFirstDecisionDisplay": "8–10 weeks", "reviewTimeType": "estimated", "deskRejectRateDisplay": "~75%", "deskRejectRateType": "estimated", "submissionWordLimitDisplay": "~5,000–7,000", "abstractFormat": "Unstructured", "abstractWordLimitDisplay": "150", "figureLimitDisplay": "7 main figures", "referenceLimitDisplay": "100", "fitSignals": [ "the host-pathogen mechanism is sharp enough to matter beyond one organism-specific niche", "the story feels complete enough for a Cell Press microbiology venue, not just promising" ], "commonRejectionReasons": [ "descriptive infection biology without enough mechanistic closure", "interesting pathogen story that feels too narrow for the journal's conceptual bar" ], "editorialModelSummary": "Cell Host & Microbe is a mechanistic host-pathogen journal with real Cell Press selectivity and a strong preference for complete conceptual stories.", "manusightsDifficultyScore": 78, "manusightsDifficultyBand": "elite", "sourceConfidence": "mixed", "sourceCount": 3, "lastReviewedAt": "2026-03-30", "versionTag": "2026.03.30-mvp1" }, { "journalSlug": "cell-stem-cell", "journalName": "Cell Stem Cell", "publisherName": "Cell Press", "fieldPrimary": "Stem Cell Biology", "openAccessModel": "hybrid", "impactFactorDisplay": "20.4", "acceptanceRateDisplay": "~10%", "acceptanceRateType": "estimated", "reviewTimeDeskDays": 38, "reviewTimeDeskDisplay": "30–45 days total", "reviewTimeFirstDecisionDays": 63, "reviewTimeFirstDecisionDisplay": "8–10 weeks", "reviewTimeType": "estimated", "deskRejectRateDisplay": "~75%", "deskRejectRateType": "estimated", "submissionWordLimitDisplay": "~5,000–7,000", "abstractFormat": "Unstructured", "abstractWordLimitDisplay": "150", "figureLimitDisplay": "7 main figures", "referenceLimitDisplay": "100", "fitSignals": [ "the paper changes how stem-cell or regenerative-biology people think, not just one technical corner", "mechanistic confidence and disease or developmental relevance are both visible" ], "commonRejectionReasons": [ "flashy regenerative angle without enough mechanistic depth", "incremental stem-cell story positioned as a major conceptual shift" ], "editorialModelSummary": "Cell Stem Cell is a selective Cell Press venue that expects both conceptual weight and a very complete evidence package.", "manusightsDifficultyScore": 80, "manusightsDifficultyBand": "extreme", "sourceConfidence": "mixed", "sourceCount": 3, "lastReviewedAt": "2026-03-30", "versionTag": "2026.03.30-mvp1" }, { "journalSlug": "circulation-research", "journalName": "Circulation Research", "publisherName": "American Heart Association", "fieldPrimary": "Cardiology", "openAccessModel": "hybrid", "impactFactorDisplay": "16.2", "acceptanceRateDisplay": "~10%", "acceptanceRateType": "estimated", "reviewTimeDeskDays": 28, "reviewTimeDeskDisplay": "21–35 days", "reviewTimeFirstDecisionDays": 49, "reviewTimeFirstDecisionDisplay": "6–8 weeks", "reviewTimeType": "estimated", "deskRejectRateDisplay": "~70%", "deskRejectRateType": "estimated", "submissionWordLimitDisplay": "~5,000", "abstractFormat": "Structured", "abstractWordLimitDisplay": "250", "figureLimitDisplay": "6 total", "referenceLimitDisplay": "60", "fitSignals": [ "the paper has clear cardiovascular-mechanism relevance and not just one narrow model-system result", "basic or translational framing maps cleanly onto the journal's cardiovascular audience" ], "commonRejectionReasons": [ "strong biology that is not clearly cardiovascular enough", "translational claims exceed what the mechanistic package can support" ], "editorialModelSummary": "Circulation Research is a selective cardiovascular journal that rewards mechanistic depth and translational cardiovascular relevance more than raw prestige signaling.", "manusightsDifficultyScore": 74, "manusightsDifficultyBand": "elite", "sourceConfidence": "mixed", "sourceCount": 3, "lastReviewedAt": "2026-03-30", "versionTag": "2026.03.30-mvp1" }, { "journalSlug": "current-biology", "journalName": "Current Biology", "publisherName": "Cell Press", "fieldPrimary": "Cell & Molecular Biology", "openAccessModel": "hybrid", "impactFactorDisplay": "7.5", "acceptanceRateDisplay": "~35%", "acceptanceRateType": "estimated", "reviewTimeDeskDays": 38, "reviewTimeDeskDisplay": "30–45 days total", "reviewTimeFirstDecisionDays": 56, "reviewTimeFirstDecisionDisplay": "6–10 weeks", "reviewTimeType": "estimated", "deskRejectRateDisplay": "~40%", "deskRejectRateType": "estimated", "submissionWordLimitDisplay": "~4,500", "abstractFormat": "Unstructured", "abstractWordLimitDisplay": "150", "figureLimitDisplay": "6 main figures", "referenceLimitDisplay": "50", "fitSignals": [ "the result is interesting and well-packaged even if it does not need a flagship Cell Press venue", "the story fits the journal's broad-biology and report-friendly format" ], "commonRejectionReasons": [ "paper is technically sound but not interesting enough even for Current Biology's broader filter", "story is too incomplete or too specialized to justify Cell Press positioning" ], "editorialModelSummary": "Current Biology is broader and less selective than top Cell Press titles, but it still rewards clear conceptual interest and clean narrative packaging.", "manusightsDifficultyScore": 48, "manusightsDifficultyBand": "selective", "sourceConfidence": "mixed", "sourceCount": 3, "lastReviewedAt": "2026-03-30", "versionTag": "2026.03.30-mvp1" }, { "journalSlug": "developmental-cell", "journalName": "Developmental Cell", "publisherName": "Cell Press", "fieldPrimary": "Developmental Biology", "openAccessModel": "hybrid", "impactFactorDisplay": "8.7", "acceptanceRateDisplay": "~18%", "acceptanceRateType": "estimated", "reviewTimeDeskDays": 38, "reviewTimeDeskDisplay": "30–45 days total", "reviewTimeFirstDecisionDays": 70, "reviewTimeFirstDecisionDisplay": "8–12 weeks", "reviewTimeType": "estimated", "deskRejectRateDisplay": "~65%", "deskRejectRateType": "estimated", "submissionWordLimitDisplay": "~5,000–7,000", "abstractFormat": "Unstructured", "abstractWordLimitDisplay": "150", "figureLimitDisplay": "7 main figures", "referenceLimitDisplay": "100", "fitSignals": [ "the developmental mechanism is clean, complete, and interesting beyond one phenotype description", "the paper feels like a real developmental-cell story rather than a narrower specialty report" ], "commonRejectionReasons": [ "developmental biology that is descriptive but not mechanistically decisive", "organism-specific result without enough broader conceptual payoff" ], "editorialModelSummary": "Developmental Cell is a selective Cell Press journal that sits below the flagship tier but still expects mechanistic completeness and a clear developmental concept.", "manusightsDifficultyScore": 61, "manusightsDifficultyBand": "elite", "sourceConfidence": "mixed", "sourceCount": 3, "lastReviewedAt": "2026-03-30", "versionTag": "2026.03.30-mvp1" }, { "journalSlug": "elife", "journalName": "eLife", "publisherName": "eLife Sciences Publications", "fieldPrimary": "Life Sciences", "openAccessModel": "gold_oa", "impactFactorDisplay": "N/A", "acceptanceRateDisplay": "~15%", "acceptanceRateType": "estimated", "reviewTimeDeskDays": 30, "reviewTimeDeskDisplay": "~30 days", "reviewTimeFirstDecisionDays": 91, "reviewTimeFirstDecisionDisplay": "10–16 weeks", "reviewTimeType": "reported", "deskRejectRateDisplay": "~50%", "deskRejectRateType": "estimated", "submissionWordLimitDisplay": "No strict limit", "abstractFormat": "Unstructured", "abstractWordLimitDisplay": "No strict limit", "figureLimitDisplay": "No strict limit", "referenceLimitDisplay": "No strict limit", "fitSignals": [ "the paper is strong enough to benefit from public review and transparent editorial assessment", "authors value rigor and openness more than legacy prestige signaling" ], "commonRejectionReasons": [ "story is too thin even for a public-review model", "methods or claims are not strong enough to support open expert scrutiny" ], "editorialModelSummary": "eLife is an open-review life-sciences venue with a distinct editorial model: public reviews, flexible format, and a meaningful but not flagship-style novelty bar.", "manusightsDifficultyScore": 44, "manusightsDifficultyBand": "selective", "sourceConfidence": "mixed", "sourceCount": 3, "lastReviewedAt": "2026-03-30", "versionTag": "2026.03.30-mvp1" }, { "journalSlug": "embo-journal", "journalName": "The EMBO Journal", "publisherName": "EMBO Press", "fieldPrimary": "Cell & Molecular Biology", "openAccessModel": "hybrid", "impactFactorDisplay": "8.3", "acceptanceRateDisplay": "~15%", "acceptanceRateType": "estimated", "reviewTimeDeskDays": 35, "reviewTimeDeskDisplay": "4–6 weeks total", "reviewTimeFirstDecisionDays": 77, "reviewTimeFirstDecisionDisplay": "8–14 weeks", "reviewTimeType": "estimated", "deskRejectRateDisplay": "~65%", "deskRejectRateType": "estimated", "submissionWordLimitDisplay": "~7,000", "abstractFormat": "Unstructured", "abstractWordLimitDisplay": "200", "figureLimitDisplay": "7 main figures", "referenceLimitDisplay": "100", "fitSignals": [ "the manuscript has a mature molecular or cell-biology story with real mechanistic closure", "the work can carry an EMBO audience without needing Cell-tier breadth" ], "commonRejectionReasons": [ "sound molecular biology that still feels one decisive experiment short", "incremental mechanism presented as a field-moving advance" ], "editorialModelSummary": "The EMBO Journal is a respected mechanistic biology venue with real selectivity, rewarding complete stories more than hype.", "manusightsDifficultyScore": 62, "manusightsDifficultyBand": "elite", "sourceConfidence": "mixed", "sourceCount": 3, "lastReviewedAt": "2026-03-30", "versionTag": "2026.03.30-mvp1" }, { "journalSlug": "jama-cardiology", "journalName": "JAMA Cardiology", "publisherName": "American Medical Association", "fieldPrimary": "Cardiology", "openAccessModel": "hybrid", "impactFactorDisplay": "14.1", "acceptanceRateDisplay": "~8%", "acceptanceRateType": "estimated", "reviewTimeDeskDays": 18, "reviewTimeDeskDisplay": "14–21 days", "reviewTimeFirstDecisionDays": 35, "reviewTimeFirstDecisionDisplay": "4–6 weeks", "reviewTimeType": "estimated", "deskRejectRateDisplay": "~80%", "deskRejectRateType": "estimated", "submissionWordLimitDisplay": "~2,800", "abstractFormat": "Structured", "abstractWordLimitDisplay": "300", "figureLimitDisplay": "5 total", "referenceLimitDisplay": "35", "fitSignals": [ "the manuscript matters to clinical cardiology, not just one research niche", "the result is concise, generalizable, and legible to the broader JAMA Network audience" ], "commonRejectionReasons": [ "good cardiovascular paper without enough practice relevance for JAMA Cardiology", "subspecialty framing that is too narrow for a general-cardiology clinical readership" ], "editorialModelSummary": "JAMA Cardiology is a fast-triage clinical-cardiology journal that rewards broad practice relevance and disciplined general-medical framing.", "manusightsDifficultyScore": 81, "manusightsDifficultyBand": "extreme", "sourceConfidence": "mixed", "sourceCount": 3, "lastReviewedAt": "2026-03-30", "versionTag": "2026.03.30-mvp1" }, { "journalSlug": "journal-of-neuroscience", "journalName": "Journal of Neuroscience", "publisherName": "Society for Neuroscience", "fieldPrimary": "Neuroscience", "openAccessModel": "hybrid", "impactFactorDisplay": "4.0", "acceptanceRateDisplay": "~25%", "acceptanceRateType": "estimated", "reviewTimeDeskDays": 53, "reviewTimeDeskDisplay": "45–60 days total", "reviewTimeFirstDecisionDays": 70, "reviewTimeFirstDecisionDisplay": "8–12 weeks", "reviewTimeType": "estimated", "deskRejectRateDisplay": "~40%", "deskRejectRateType": "estimated", "submissionWordLimitDisplay": "~10,000", "abstractFormat": "Structured", "abstractWordLimitDisplay": "250", "figureLimitDisplay": "10 total", "referenceLimitDisplay": "No strict limit", "fitSignals": [ "the study is methodologically rigorous even if it does not need a flagship neuroscience venue", "the neuroscience question is clear and the evidence is complete enough for a society journal audience" ], "commonRejectionReasons": [ "insufficient rigor or underpowered experiments despite a more accessible selectivity bar", "story is too incremental or not clearly meaningful to a broad neuroscience readership" ], "editorialModelSummary": "Journal of Neuroscience is more accessible than top-tier neuroscience journals, but it still expects solid methodology and a clearly worthwhile neuroscience question.", "manusightsDifficultyScore": 43, "manusightsDifficultyBand": "selective", "sourceConfidence": "mixed", "sourceCount": 3, "lastReviewedAt": "2026-03-30", "versionTag": "2026.03.30-mvp1" }, { "journalSlug": "lancet-infectious-diseases", "journalName": "Lancet Infectious Diseases", "publisherName": "Elsevier", "fieldPrimary": "Infectious Diseases", "openAccessModel": "hybrid", "impactFactorDisplay": "31.0", "acceptanceRateDisplay": "~12%", "acceptanceRateType": "estimated", "reviewTimeDeskDays": 21, "reviewTimeDeskDisplay": "2–4 weeks", "reviewTimeFirstDecisionDays": 56, "reviewTimeFirstDecisionDisplay": "6–10 weeks", "reviewTimeType": "estimated", "deskRejectRateDisplay": ">85%", "deskRejectRateType": "estimated", "submissionWordLimitDisplay": "~3,000", "abstractFormat": "Structured", "abstractWordLimitDisplay": "250", "figureLimitDisplay": "5 total", "referenceLimitDisplay": "60", "fitSignals": [ "the study has obvious infectious-disease or global-health consequence beyond a narrow pathogen story", "the paper carries enough policy, clinical, or epidemiologic relevance for a Lancet specialty title" ], "commonRejectionReasons": [ "important infectious-disease data without enough broad consequence for the Lancet family", "regional or mechanistic interest presented as field-wide or global-health importance" ], "editorialModelSummary": "Lancet Infectious Diseases is a high-selectivity specialty flagship that screens hard for broad infectious-disease consequence and clear clinical or public-health relevance.", "manusightsDifficultyScore": 86, "manusightsDifficultyBand": "extreme", "sourceConfidence": "mixed", "sourceCount": 3, "lastReviewedAt": "2026-03-30", "versionTag": "2026.03.30-mvp1" }, { "journalSlug": "lancet-neurology", "journalName": "Lancet Neurology", "publisherName": "Elsevier", "fieldPrimary": "Neuroscience", "openAccessModel": "hybrid", "impactFactorDisplay": "45.5", "acceptanceRateDisplay": "~10%", "acceptanceRateType": "estimated", "reviewTimeDeskDays": 21, "reviewTimeDeskDisplay": "2–4 weeks", "reviewTimeFirstDecisionDays": 49, "reviewTimeFirstDecisionDisplay": "6–8 weeks", "reviewTimeType": "estimated", "deskRejectRateDisplay": ">85%", "deskRejectRateType": "estimated", "submissionWordLimitDisplay": "~3,000", "abstractFormat": "Structured", "abstractWordLimitDisplay": "250", "figureLimitDisplay": "5 total", "referenceLimitDisplay": "60", "fitSignals": [ "the paper matters to neurology practice or field-wide neurologic thinking, not only one neuroscience niche", "clinical-translational relevance is unmistakable from the first screen" ], "commonRejectionReasons": [ "good neurology research without enough broad specialty consequence for a Lancet title", "bench-heavy story with weaker clinical or neurologic practice relevance than advertised" ], "editorialModelSummary": "Lancet Neurology is a premier neurology journal with rapid triage and a very high bar for field-wide clinical or translational consequence.", "manusightsDifficultyScore": 89, "manusightsDifficultyBand": "extreme", "sourceConfidence": "mixed", "sourceCount": 3, "lastReviewedAt": "2026-03-30", "versionTag": "2026.03.30-mvp1" }, { "journalSlug": "molecular-psychiatry", "journalName": "Molecular Psychiatry", "publisherName": "Springer Nature", "fieldPrimary": "Psychiatry", "openAccessModel": "hybrid", "impactFactorDisplay": "10.1", "acceptanceRateDisplay": "~12%", "acceptanceRateType": "estimated", "reviewTimeDeskDays": 53, "reviewTimeDeskDisplay": "45–60 days total", "reviewTimeFirstDecisionDays": 77, "reviewTimeFirstDecisionDisplay": "10–12 weeks", "reviewTimeType": "estimated", "deskRejectRateDisplay": "~65%", "deskRejectRateType": "estimated", "submissionWordLimitDisplay": "~4,000", "abstractFormat": "Unstructured", "abstractWordLimitDisplay": "200", "figureLimitDisplay": "6 total", "referenceLimitDisplay": "60", "fitSignals": [ "the paper connects neuroscience or genetics to psychiatry in a way that feels clinically or conceptually durable", "human relevance is visible rather than purely implied" ], "commonRejectionReasons": [ "interesting neuroscience with weak psychiatric consequence", "association-heavy story without enough mechanistic or translational force" ], "editorialModelSummary": "Molecular Psychiatry sits at the psychiatry-neuroscience interface and rewards papers with both mechanistic credibility and clear psychiatric relevance.", "manusightsDifficultyScore": 71, "manusightsDifficultyBand": "elite", "sourceConfidence": "mixed", "sourceCount": 3, "lastReviewedAt": "2026-03-30", "versionTag": "2026.03.30-mvp1" }, { "journalSlug": "nature-chemical-biology", "journalName": "Nature Chemical Biology", "publisherName": "Springer Nature", "fieldPrimary": "Chemical Biology", "openAccessModel": "hybrid", "impactFactorDisplay": "13.7", "acceptanceRateDisplay": "~15%", "acceptanceRateType": "estimated", "reviewTimeDeskDays": 38, "reviewTimeDeskDisplay": "30–45 days total", "reviewTimeFirstDecisionDays": 70, "reviewTimeFirstDecisionDisplay": "8–12 weeks", "reviewTimeType": "estimated", "deskRejectRateDisplay": ">75%", "deskRejectRateType": "estimated", "submissionWordLimitDisplay": "~3,000", "abstractFormat": "Unstructured", "abstractWordLimitDisplay": "150", "figureLimitDisplay": "6 display items", "referenceLimitDisplay": "50", "fitSignals": [ "the chemistry changes a biological question rather than decorating it", "the story feels genuinely chemical-biology in identity, not just chemistry applied to biology" ], "commonRejectionReasons": [ "good chemistry or good biology, but the integration between them is weak", "tool or probe paper without enough conceptual biological consequence" ], "editorialModelSummary": "Nature Chemical Biology is selective about true chemical-biology identity and filters out papers that lean too far toward either pure chemistry or pure biology alone.", "manusightsDifficultyScore": 78, "manusightsDifficultyBand": "elite", "sourceConfidence": "mixed", "sourceCount": 3, "lastReviewedAt": "2026-03-30", "versionTag": "2026.03.30-mvp1" }, { "journalSlug": "nature-neuroscience", "journalName": "Nature Neuroscience", "publisherName": "Springer Nature", "fieldPrimary": "Neuroscience", "openAccessModel": "hybrid", "impactFactorDisplay": "20.0", "acceptanceRateDisplay": "~9%", "acceptanceRateType": "estimated", "reviewTimeDeskDays": 53, "reviewTimeDeskDisplay": "45–60 days", "reviewTimeFirstDecisionDays": 98, "reviewTimeFirstDecisionDisplay": "12–16 weeks", "reviewTimeType": "estimated", "deskRejectRateDisplay": ">85%", "deskRejectRateType": "estimated", "submissionWordLimitDisplay": "~3,500", "abstractFormat": "Unstructured", "abstractWordLimitDisplay": "150", "figureLimitDisplay": "8 display items", "referenceLimitDisplay": "60", "fitSignals": [ "the neuroscience claim feels both field-shaping and robust to skeptical specialist review", "the paper justifies the journal's longer editorial assessment because the consequence is genuinely high" ], "commonRejectionReasons": [ "strong neuroscience without enough conceptual lift for Nature Neuroscience", "headline claim is exciting but the causal or mechanistic support is still too thin" ], "editorialModelSummary": "Nature Neuroscience is a high-bar neuroscience flagship with slower editorial assessment and a premium on both conceptual importance and evidentiary strength.", "manusightsDifficultyScore": 91, "manusightsDifficultyBand": "extreme", "sourceConfidence": "mixed", "sourceCount": 3, "lastReviewedAt": "2026-03-30", "versionTag": "2026.03.30-mvp1" }, { "journalSlug": "nature-structural-molecular-biology", "journalName": "Nature Structural & Molecular Biology", "publisherName": "Springer Nature", "fieldPrimary": "Structural Biology", "openAccessModel": "hybrid", "impactFactorDisplay": "10.1", "acceptanceRateDisplay": "~12%", "acceptanceRateType": "estimated", "reviewTimeDeskDays": 38, "reviewTimeDeskDisplay": "30–45 days total", "reviewTimeFirstDecisionDays": 70, "reviewTimeFirstDecisionDisplay": "8–12 weeks", "reviewTimeType": "estimated", "deskRejectRateDisplay": ">80%", "deskRejectRateType": "estimated", "submissionWordLimitDisplay": "~3,000", "abstractFormat": "Unstructured", "abstractWordLimitDisplay": "150", "figureLimitDisplay": "6 display items", "referenceLimitDisplay": "50", "fitSignals": [ "the structural insight changes biological understanding rather than adding a narrower structure report", "the molecular story is both technically strong and conceptually meaningful" ], "commonRejectionReasons": [ "high-quality structure without enough broader biological consequence", "mechanistic story remains too incremental for a Nature specialty title" ], "editorialModelSummary": "Nature Structural & Molecular Biology is selective about conceptual payoff and rejects many technically strong structure papers that do not change the biology enough.", "manusightsDifficultyScore": 82, "manusightsDifficultyBand": "extreme", "sourceConfidence": "mixed", "sourceCount": 3, "lastReviewedAt": "2026-03-30", "versionTag": "2026.03.30-mvp1" }, { "journalSlug": "plos-medicine", "journalName": "PLOS Medicine", "publisherName": "PLOS", "fieldPrimary": "Clinical Medicine", "openAccessModel": "gold_oa", "impactFactorDisplay": "9.9", "acceptanceRateDisplay": "~15%", "acceptanceRateType": "estimated", "reviewTimeDeskDays": 49, "reviewTimeDeskDisplay": "6–8 weeks total", "reviewTimeFirstDecisionDays": 84, "reviewTimeFirstDecisionDisplay": "10–14 weeks", "reviewTimeType": "estimated", "deskRejectRateDisplay": "~50%", "deskRejectRateType": "estimated", "submissionWordLimitDisplay": "~3,000", "abstractFormat": "Structured", "abstractWordLimitDisplay": "300", "figureLimitDisplay": "5 total", "referenceLimitDisplay": "50", "fitSignals": [ "the paper has real clinical or public-health consequence and fits an open-access general-medicine audience", "methods and transparency are strong enough to support broad medical trust" ], "commonRejectionReasons": [ "important clinical study without enough public-health or general-medicine consequence", "open-access framing cannot rescue a paper with weak reporting or limited impact" ], "editorialModelSummary": "PLOS Medicine is a selective OA medicine journal with a broad clinical and public-health scope, rewarding rigor and consequence more than prestige theater.", "manusightsDifficultyScore": 58, "manusightsDifficultyBand": "selective", "sourceConfidence": "mixed", "sourceCount": 3, "lastReviewedAt": "2026-03-30", "versionTag": "2026.03.30-mvp1" }, { "journalSlug": "science-translational-medicine", "journalName": "Science Translational Medicine", "publisherName": "AAAS", "fieldPrimary": "Translational Medicine", "openAccessModel": "hybrid", "impactFactorDisplay": "14.6", "acceptanceRateDisplay": "~15%", "acceptanceRateType": "estimated", "reviewTimeDeskDays": 42, "reviewTimeDeskDisplay": "4–8 weeks total", "reviewTimeFirstDecisionDays": 77, "reviewTimeFirstDecisionDisplay": "8–14 weeks", "reviewTimeType": "estimated", "deskRejectRateDisplay": "~75%", "deskRejectRateType": "estimated", "submissionWordLimitDisplay": "~4,500", "abstractFormat": "Structured", "abstractWordLimitDisplay": "225", "figureLimitDisplay": "8 display items", "referenceLimitDisplay": "60", "fitSignals": [ "the paper truly bridges bench and bedside instead of only borrowing translational language", "human or near-clinical consequence is visible in the evidence package" ], "commonRejectionReasons": [ "strong basic science with weaker translational traction than the framing suggests", "translational claim is real but still too early or under-supported for the journal" ], "editorialModelSummary": "Science Translational Medicine is a selective translational journal that rewards credible bench-to-bedside consequence rather than generic translational branding.", "manusightsDifficultyScore": 83, "manusightsDifficultyBand": "extreme", "sourceConfidence": "mixed", "sourceCount": 3, "lastReviewedAt": "2026-03-30", "versionTag": "2026.03.30-mvp1" }, { "journalSlug": "plos-one", "journalName": "PLOS ONE", "publisherName": "PLOS", "fieldPrimary": "Multidisciplinary", "openAccessModel": "gold_oa", "impactFactorDisplay": "2.6", "acceptanceRateDisplay": "~31%", "acceptanceRateType": "reported", "reviewTimeDeskDays": 40, "reviewTimeDeskDisplay": "~40 days total", "reviewTimeFirstDecisionDays": 70, "reviewTimeFirstDecisionDisplay": "8–12 weeks", "reviewTimeType": "reported", "deskRejectRateDisplay": "~30%", "deskRejectRateType": "estimated", "fitSignals": [ "methods and reporting are clean enough for a soundness-based venue", "the paper is framed around validity rather than prestige signaling" ], "commonRejectionReasons": [ "methods or reporting problems that still fail a soundness bar", "unsupported claims or weak transparency" ], "editorialModelSummary": "PLOS ONE is a soundness-first OA venue with a much lower novelty bar than prestige journals, but still a real rigor and reporting filter.", "manusightsDifficultyScore": 41, "manusightsDifficultyBand": "selective", "sourceConfidence": "medium", "sourceCount": 4, "lastReviewedAt": "2026-03-30", "versionTag": "2026.03.30-mvp1" }, { "journalSlug": "scientific-reports", "journalName": "Scientific Reports", "publisherName": "Springer Nature", "fieldPrimary": "Multidisciplinary", "openAccessModel": "gold_oa", "impactFactorDisplay": "3.9", "acceptanceRateDisplay": "~57%", "acceptanceRateType": "estimated", "reviewTimeDeskDays": 120, "reviewTimeDeskDisplay": "~120 days total", "reviewTimeFirstDecisionDays": 112, "reviewTimeFirstDecisionDisplay": "14–20 weeks", "reviewTimeType": "estimated", "deskRejectRateDisplay": "~20%", "deskRejectRateType": "estimated", "fitSignals": [ "the study is technically sound and publishable even without prestige-tier novelty", "authors are making a realistic reach-versus-selectivity tradeoff" ], "commonRejectionReasons": [ "weak methods or unsupported claims even in a lower-selectivity venue", "sloppy reporting that undermines trust in otherwise sound work" ], "editorialModelSummary": "Scientific Reports is a high-volume OA venue with a lower novelty threshold than flagships, but it still rejects weakly supported or poorly reported work.", "manusightsDifficultyScore": 34, "manusightsDifficultyBand": "accessible", "sourceConfidence": "mixed", "sourceCount": 3, "lastReviewedAt": "2026-03-30", "versionTag": "2026.03.30-mvp1" }, { "journalSlug": "frontiers-in-immunology", "journalName": "Frontiers in Immunology", "publisherName": "Frontiers", "fieldPrimary": "Immunology", "openAccessModel": "gold_oa", "impactFactorDisplay": "5.9", "acceptanceRateDisplay": "~40%", "acceptanceRateType": "estimated", "reviewTimeDeskDays": 80, "reviewTimeDeskDisplay": "~80 days total", "reviewTimeFirstDecisionDays": 98, "reviewTimeFirstDecisionDisplay": "12–16 weeks", "reviewTimeType": "estimated", "deskRejectRateDisplay": "~30%", "deskRejectRateType": "estimated", "fitSignals": [ "the study is technically solid and clearly within section scope", "authors are optimizing for soundness and visibility rather than prestige filtering" ], "commonRejectionReasons": [ "section mismatch or weak specialty framing", "methods or evidence gaps that fail even a soundness-oriented review model" ], "editorialModelSummary": "Frontiers in Immunology is a broad OA immunology venue with collaborative review and a materially lower novelty threshold than top-tier immunology journals.", "manusightsDifficultyScore": 38, "manusightsDifficultyBand": "accessible", "sourceConfidence": "mixed", "sourceCount": 3, "lastReviewedAt": "2026-03-30", "versionTag": "2026.03.30-mvp1" } ]